Miller Anestesia

107. Ebert TJ, Messana LD, Uhrich TD, et al: Absence of

renal and hepatic toxicity after four hours of 1.25

minimum alveolar anesthetic concentration sevo-

flurane anesthesia in volunteers. Anesth Analg

86:662–667, 1998.

108. Ebert TJ, Frink EJ Jr, Kharasch ED: Absence of bio-

chemical evidence for renal and hepatic dysfunction

after 8hours of 1.25 minimum alveolar concentra-

tion sevoflurane anesthesia in volunteers. Anesthe-

siology 88:601–610, 1998.

109. Eger EI, 2nd, Koblin DD, Bowland T, et al: Nephro-

toxicity of sevoflurane versus desflurane anesthesia

in volunteers. Anesth Analg 84:160–168, 1997.

110. Frink EJ Jr, Malan TP Jr, Isner RJ, et al: Renal con-

centrating function with prolonged sevoflurane or

enflurane anesthesia in volunteers. Anesthesiology

80:1019–1025, 1994.

111. Artru AA: Renal effects of sevoflurane during con-

ditions of possible increased risk. J Clin Anesth

10:531–538, 1998.

112. Nishimori A, Tanaka K, Ueno K, et al: Effects of

sevoflurane anaesthesia on renal function. J Int Med

Res 25:87–91, 1997.

113. Conzen PF, Kharasch ED, Czerner FA, et al: Low-

flow sevoflurane compared with low-flow isoflurane

anesthesia in patients with stable renal insufficiency.

Anesthesiology 97:578–584, 2002.

114. Sear JW: Sufentanil disposition in patients under-

going renal transplantation: Influence of choice of

kinetic model. Br J Anaesth 63:60–67, 1989.

115. Kirvela M, Lindgren L, Seppala T, et al: The pharma-

cokinetics of oxycodone in uremic patients under-

going renal transplantation. J Clin Anesth 8:13–18,

1996.

116. Angst MS, Buhrer M, Lotsch J: Insidious intoxica-

tion after morphine treatment in renal failure:

Delayed onset of morphine-6-glucuronide action.

Anesthesiology 92:1473–1476, 2000.

117. Fyman PN, Reynolds JR, Moser F, et al: Pharmaco-

kinetics of sufentanil in patients undergoing renal

transplantation. Can J Anaesth 35(Pt 1): 312–315,

1988.

118. Michelsen LG, Hug CC Jr: The pharmacokinetics of

remifentanil. J Clin Anesth 8:679–682, 1996.

119. Hoke JF, Cunningham F, James MK, et al: Compa-

rative pharmacokinetics and pharmacodynamics of

remifentanil, its principle metabolite (GR90291)

and alfentanil in dogs. J Pharmacol Exp Ther

281:226–232, 1997.

120. Morita K, Seki T, Nonomura K, et al: Changes in

renal blood flow in response to sympathomimetics

in the rat transplanted and denervated kidney. Int J

Urol 6:24–32, 1999.

121. Gabriels G, August C, Grisk O, et al: Impact of renal

transplantation on small vessel reactivity. Trans-

plantation 75:689–697, 2003.

122. Koning OH, Ploeg RJ, van Bockel JH, et al: Risk

factors for delayed graft function in cadaveric

kidney transplantation: A prospective study of renal

function and graft survival after preservation with

University of Wisconsin solution in multi-organ

donors. European Multicenter Study Group. Trans-

plantation 63:1620–1628, 1997.

123. Carmellini M, Romagnoli J, Giulianotti PC, et al:

Dopamine lowers the incidence of delayed graft

function in transplanted kidney patients treated

with cyclosporine A. Transplant Proc 26:2626–2629,

1994.

124. Kadieva VS, Friedman L, Margolius LP, et al: The

effect of dopamine on graft function in patients

undergoing renal transplantation. Anesth Analg

76:362–365, 1993.

125. Sandberg J, Tyden G, Groth CG: Low-dose dopa-

mine infusion following cadaveric renal transplan-

tation: No effect on the incidence of ATN. Transplant

Proc 24:357, 1992.

126. Spicer ST, Gruenewald S, O’Connell PJ, et al: Low-

dose dopamine after kidney transplantation:

Assessment by Doppler ultrasound. Clin Transpl

13:479–483, 1999.

127. Kogan A, Singer P, Cohen J, et al: Readmission to an

intensive care unit following liver and kidney trans-

plantation: A 50-month study. Transplant Proc

31:1892–1893, 1999.

128. Lazowski T: The influence of the type of anaesthesia

on postoperative pain after kidney transplantation.

Ann Transplant 5:28–29, 2000.

129. Knowles P, Hancox D, Letheren M, et al: An evalua-

tion of intercostal nerve blockade for analgesia

following renal transplantation. Eur J Anaesthesiol

15:457–461, 1998.

130. Gill JS, Tonelli M, Mix CH, et al: The change in allo-

graft function among long-term kidney transplant

recipients. J Am Soc Nephrol 14:1636–1642, 2003.

131. Schankel K, Robinson J, Bloom RD, et al: Determi-

nants of coronary artery calcification progression in

renal transplant recipients. Am J Transplant 7:2158–

2164, 2007.

132. John R, Lietz K, Huddleston S, et al: Perioperative

outcomes of cardiac surgery in kidney and kidney-

pancreas transplant recipients. J Thorac Cardiovasc

Surg 133:1212–1219, 2007.

133. Ponticelli C, Villa M: Role of anaemia in cardiovas-

cular mortality and morbidity in transplant patients.

Nephrol Dial Transplant 17(Suppl 1): 41–46, 2002.

134. Legendre C, Campistol JM, Squifflet JP, et al: Cardio-

vascular risk factors of sirolimus compared with

cyclosporine: Early experience from two randomi-

zed trials in renal transplantation. Transplant Proc

35(3 Suppl): S151–S153, 2003.

135. Gruessner RW, Bartlett ST, Burke GW, et al: Sugges-

ted guidelines for the use of tacrolimus in pancreas/

kidney transplantation. Clin Transpl 12:260–262,

1998.

136. Reddy KS, Stablein D, Taranto S, et al: Long-term

survival following simultaneous kidney-pancreas

transplantation versus kidney transplantation alone

in patients with type 1 diabetes mellitus and renal

failure. Am J Kidney Dis 41:464–470, 2003.

137. Kirvela M, Salmela K, Toivonen L, et al: Heart rate

variability in diabetic and non-diabetic renal trans-

plant patients. Acta Anaesthesiol Scand 40:804–808,

1996.

138. Oppert M, Schneider U, Bocksch W, et al: Improve-

ment of left ventricular function and arterial blood

pressure 1 year after simultaneous pancreas kidney

transplantation. Transplant Proc 34:2251–2252,

2002.

139. Warner ME, Contreras MG, Warner MA, et al: Dia-

betes mellitus and difficult laryngoscopy in renal

and pancreatic transplant patients. Anesth Analg

86:516–519, 1998.

140. Halpern H, Miyoshi E, Kataoka LM, et al: Anesthesia

for pancreas transplantation alone or simultaneous

with kidney. Transpl Proc 36:3105–3106, 2004.

141. Kirvela M, Scheinin M, Lindgren L: Haemodynamic

and catecholamine responses to induction of anaesthe-

sia and tracheal intubation in diabetic and non-diabe-

tic uraemic patients. Br J Anaesth 74:60–65, 1995.

142. Sieber FE: The neurologic implications of diabetic

hyperglycemia during surgical procedures at increa-

sed risk for brain ischemia. J Clin Anesth 9:334–340,

1997.

143. Hemmerling TM, Schmid MC, Schmidt J, et al:

Comparison of a continuous glucose-insulin-potas-

sium infusion versus intermittent bolus application

of insulin on perioperative glucose control and

hormone status in insulin-treated type 2 diabetics. J

Clin Anesth 13:293–300, 2001.

144. Roberts JP, Brown RS Jr, Edwards EB, et al: Liver and

intestine transplantation. Am J Transplant 3(Suppl

4)78–90, 2003.

145. Kim FJ, Ratner LE, Kavoussi LR: Renal transplanta-

tion: Laparoscopic live donor nephrectomy. Urol

Clin North Am 27:777–785, 2000.

146. Kim WR: The burden of hepatitis C in the United

States. Hepatology 36(5 Suppl)S30–S34, 2002.

147. Wiesner RH, Rakela J, Ishitani MB, et al: Recent

advances in liver transplantation. Mayo Clin Proc

78:197–210, 2003.

148. Futagawa Y, Terasaki PI, Waki K, et al: No improve-

ment in long-term liver transplant graft survival in

the last decade: An analysis of the UNOS data. Am

J Transplant 6:1398–1406, 2006.

149. Davis CL, Gonwa TA, Wilkinson AH: Identification of

patients best suited for combined liver-kidney trans-

plantation, part II. Liver Transpl 8:193–211, 2002.

150. Rydberg L: ABO-incompatibility in solid organ

transplantation. Transfus Med 11:325–342, 2001.

151. Bjoro K, Ericzon BG, Kirkegaard P, et al: Highly

urgent liver transplantation: Possible impact of

donor-recipient ABOmatching on the outcome after

transplantation. Transplantation 75:347–353, 2003.

152. Vaquero J, Blei AT: Etiology and management of

fulminant hepatic failure. Curr Gastroenterol Rep

5:39–47, 2003.

153. Fujiwara K, Mochida S: Indications and criteria for

liver transplantation for fulminant hepatic failure. J

Gastroenterol 37(Suppl 13): 74–77, 2002.

154. Wiesner RH, McDiarmid SV, Kamath PS, et al:

MELD and PELD: Application of survival models to

liver allocation. Liver Transpl 7:567–580, 2001.

155. Freeman RB Jr, Wiesner RH, Harper A, et al: The

new liver allocation system: Moving toward evi-

dence-based transplantation policy. Liver Transpl

8:851–858, 2002.

156. Figueiredo F, Dickson ER, Pasha T, et al: Impact of

nutritional status on outcomes after liver transplan-

tation. Transplantation 70:1347–1352, 2000.

157. Freeman RB, Harper AM, Edwards EB: Redrawing

organ distribution boundaries: Results of a compu-

ter-simulated analysis for liver transplantation.

Liver Transpl 8:659–666, 2002.

158. Roberts JP: Prioritization of patients with liver

cancer within the MELD system. Liver Transpl

8:329–330, 2002.

159. Saab S, Wang V, Ibrahim AB, et al: MELD score pre-

dicts 1-year patient survival post-orthotopic liver

transplantation. Liver Transpl 9:473–476, 2003.

160. Wongcharatrawee S, Groszmann RJ: Diagnosing

portal hypertension. Baillieres Best Pract Res Clin

Gastroenterol 14:881–894, 2000.

161. Groszmann RJ: Hyperdynamic circulation of liver

disease 40 years later: Pathophysiology and clinical

consequences. Hepatology 20:1359–1363, 1994.

162. Cardenas A, Gines P: Pathogenesis and treatment of

fluid and electrolyte imbalance in cirrhosis. Semin

Nephrol 21:308–316, 2001.

163. Merritt WT: Metabolism and liver transplantation:

Review of perioperative issues. Liver Transpl 6(4

Suppl 1)S76–S84, 2000.

164. Blei AT: Brain edema and portal-systemic encepha-

lopathy. Liver Transpl 6(4 Suppl 1): S14–S20, 2000.

165. Abou-Assi S, Vlahcevic ZR: Hepatic encephalopa-

thy: Metabolic consequence of cirrhosis often is

reversible. Postgrad Med 109:52–54, 2001.

166. Bass NM: Monitoring and treatment of intracranial

hypertension. Liver Transpl 6(4 Suppl 1): S21–S26,

2000.

167. Stravitz RT, Kramer AH, Davern T, et al: Acute Liver

Failure Study Group: Intensive care of patients with

acute liver failure: Recommendations of the U.S.

Acute Liver Failure Study Group. Crit Care Med

35:2498–2508, 2007.

168. Sorkine P, Ben Abraham R, Szold O, et al: Role of the

molecular adsorbent recycling system (MARS) in the

treatmentofpatientswithacuteexacerbationofchronic

liver failure. Crit Care Med 29:1332–1336, 2001.

Anestesia en el trasplante de órganos abdominales

1947

Sección IV

Anestesia por subespecialidades en el adulto